• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞在原发性肝细胞癌中的作用及其相关靶向治疗

The role of tumor-associated macrophages in primary hepatocellular carcinoma and its related targeting therapy.

作者信息

Deng Lu, He Kang, Pan Yixiao, Wang Hai, Luo Yi, Xia Qiang

机构信息

Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Int J Med Sci. 2021 Mar 15;18(10):2109-2116. doi: 10.7150/ijms.56003. eCollection 2021.

DOI:10.7150/ijms.56003
PMID:33859517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8040428/
Abstract

Liver macrophages consist of ontogenically distinct populations termed Kupffer cells and monocyte-derived macrophages. Tumor-associated macrophages (TAMs) inhepatocellularcarcinoma (HCC) play a prominent role in tumormicroenvironment by presenting M1(induced by IFN γ along with LPS) and M2(induced by IL-4 and IL13) polarization. Although TAMs are involved in tumor immune surveillance during the course of HCC, they contribute to tumour progression at different levels by inhibiting the anti-tumor immune response, promoting the generation of blood vessels and lymphatic vessels, and supporting the proliferation and survival of tumor cells. In this paper, the multiple functions of TAMs in HCC were reviewed to provide assistance for future researches about therapeutic approaches.

摘要

肝巨噬细胞由在个体发生上不同的群体组成,即库普弗细胞和单核细胞衍生的巨噬细胞。肝细胞癌(HCC)中的肿瘤相关巨噬细胞(TAM)通过呈现M1(由IFNγ和LPS诱导)和M2(由IL-4和IL13诱导)极化,在肿瘤微环境中发挥重要作用。尽管TAM在HCC病程中参与肿瘤免疫监视,但它们通过抑制抗肿瘤免疫反应、促进血管和淋巴管生成以及支持肿瘤细胞的增殖和存活,在不同水平上促进肿瘤进展。本文综述了TAM在HCC中的多种功能,为未来治疗方法的研究提供帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/8040428/8c641ede556a/ijmsv18p2109g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/8040428/0bd91c414c10/ijmsv18p2109g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/8040428/8c641ede556a/ijmsv18p2109g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/8040428/0bd91c414c10/ijmsv18p2109g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/8040428/8c641ede556a/ijmsv18p2109g002.jpg

相似文献

1
The role of tumor-associated macrophages in primary hepatocellular carcinoma and its related targeting therapy.肿瘤相关巨噬细胞在原发性肝细胞癌中的作用及其相关靶向治疗
Int J Med Sci. 2021 Mar 15;18(10):2109-2116. doi: 10.7150/ijms.56003. eCollection 2021.
2
Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.干扰素 γ 抑制 CXCL8-CXCR2 轴介导的肿瘤相关巨噬细胞肿瘤转移,并增强胰腺癌中抗 PD-1 的疗效。
J Immunother Cancer. 2020 Feb;8(1). doi: 10.1136/jitc-2019-000308.
3
β,β-Dimethylacrylalkannin, a Natural Naphthoquinone, Inhibits the Growth of Hepatocellular Carcinoma Cells by Modulating Tumor-Associated Macrophages.β,β-二甲基丙烯酰基紫草素,一种天然萘醌,通过调节肿瘤相关巨噬细胞抑制肝癌细胞的生长。
Molecules. 2024 Aug 20;29(16):3919. doi: 10.3390/molecules29163919.
4
Macrophages as Targets in Hepatocellular Carcinoma Therapy.巨噬细胞作为肝细胞癌治疗的靶点。
Mol Cancer Ther. 2024 Jun 4;23(6):780-790. doi: 10.1158/1535-7163.MCT-23-0660.
5
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment.一种用于治疗肝细胞癌的高选择性和强效 CXCR4 拮抗剂。
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13). doi: 10.1073/pnas.2015433118.
6
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.乐伐替尼联合抗程序性细胞死亡蛋白1在小鼠中的免疫调节作用及肝细胞癌患者富集的理论依据
Hepatology. 2021 Nov;74(5):2652-2669. doi: 10.1002/hep.32023. Epub 2021 Sep 27.
7
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.提高免疫疗法治疗肝细胞癌抗肿瘤效果的策略。
Front Immunol. 2021 Nov 26;12:783236. doi: 10.3389/fimmu.2021.783236. eCollection 2021.
8
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.骨桥蛋白诱导集落刺激因子 1 信号破坏肿瘤相关巨噬细胞的迁移,使肝细胞癌对抗 PD-L1 阻断敏感。
Gut. 2019 Sep;68(9):1653-1666. doi: 10.1136/gutjnl-2019-318419. Epub 2019 Mar 22.
9
Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma.免疫细胞的代谢重编程:塑造肝细胞癌的肿瘤微环境。
Cancer Med. 2021 Sep;10(18):6374-6383. doi: 10.1002/cam4.4177. Epub 2021 Aug 13.
10
Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy.肿瘤相关巨噬细胞在肝细胞癌中的作用:影响、机制与治疗。
Front Immunol. 2024 Aug 7;15:1429812. doi: 10.3389/fimmu.2024.1429812. eCollection 2024.

引用本文的文献

1
WNT/β-catenin-M2 macrophage interplay as a target for therapy against hepatocellular carcinoma: Role of .WNT/β-连环蛋白与M2巨噬细胞的相互作用作为肝细胞癌治疗靶点:……的作用
World J Gastroenterol. 2025 Jan 21;31(3):99983. doi: 10.3748/wjg.v31.i3.99983.
2
Application of nanotechnology in the treatment of hepatocellular carcinoma.纳米技术在肝细胞癌治疗中的应用。
Front Pharmacol. 2024 Nov 29;15:1438819. doi: 10.3389/fphar.2024.1438819. eCollection 2024.
3
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.

本文引用的文献

1
Individualized precision treatment: Targeting TAM in HCC.个体化精准治疗:肝癌中的 TAM 靶向治疗。
Cancer Lett. 2019 Aug 28;458:86-91. doi: 10.1016/j.canlet.2019.05.019. Epub 2019 May 24.
2
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.纤维蛋白原样蛋白 1 是 LAG-3 的主要免疫抑制配体。
Cell. 2019 Jan 10;176(1-2):334-347.e12. doi: 10.1016/j.cell.2018.11.010. Epub 2018 Dec 20.
3
Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.
超越癌细胞:肿瘤微环境如何推动癌症进展。
Cells. 2024 Oct 9;13(19):1666. doi: 10.3390/cells13191666.
4
Monocyte distribution width as a promising biomarker for differential diagnosis of chronic hepatitis, cirrhosis, and hepatocellular carcinoma.单核细胞分布宽度作为一种有前途的生物标志物,可用于慢性肝炎、肝硬化和肝细胞癌的鉴别诊断。
Front Immunol. 2024 Jul 3;15:1406671. doi: 10.3389/fimmu.2024.1406671. eCollection 2024.
5
Identification of a Macrophage marker gene signature to evaluate immune infiltration and therapeutic response in hepatocellular carcinoma.鉴定巨噬细胞标记基因特征以评估肝细胞癌中的免疫浸润和治疗反应。
Heliyon. 2024 May 27;10(11):e31881. doi: 10.1016/j.heliyon.2024.e31881. eCollection 2024 Jun 15.
6
Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.巨噬细胞和肥大细胞在肝癌切除术后微环境中的预后作用。
BMC Cancer. 2024 Jan 29;24(1):142. doi: 10.1186/s12885-024-11904-8.
7
The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review.肿瘤相关巨噬细胞在肝细胞癌进展中的作用:叙述性综述。
Cancer Med. 2023 Dec;12(24):22109-22129. doi: 10.1002/cam4.6717. Epub 2023 Dec 14.
8
Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC).肝癌(HCC)中的巨噬细胞代谢、表型、功能和治疗。
J Transl Med. 2023 Nov 15;21(1):815. doi: 10.1186/s12967-023-04716-0.
9
Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells.葡萄糖代谢重编程促进肝癌细胞的免疫逃逸。
Explor Target Antitumor Ther. 2023;4(3):519-536. doi: 10.37349/etat.2023.00149. Epub 2023 Jun 30.
10
Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies.肝脏定向治疗的潜在免疫治疗靶点,以及肝脏相关恶性肿瘤免疫治疗的当前范围。
Cancers (Basel). 2023 May 5;15(9):2624. doi: 10.3390/cancers15092624.
当前靶向治疗对肝细胞癌的免疫调节作用:对免疫治疗未来的启示。
Semin Liver Dis. 2018 Nov;38(4):379-388. doi: 10.1055/s-0038-1673621. Epub 2018 Oct 24.
4
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
5
Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.肝肿瘤细胞与巨噬细胞间通过 Wnt/β-catenin 信号通路的串扰促进 M2 样巨噬细胞极化并增强肿瘤恶性行为。
Cell Death Dis. 2018 Jul 18;9(8):793. doi: 10.1038/s41419-018-0818-0.
6
MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma.微小RNA-98调节巨噬细胞极化,并抑制肿瘤相关巨噬细胞对促进肝细胞癌侵袭和上皮-间质转化的作用。
Cancer Cell Int. 2018 Jul 6;18:95. doi: 10.1186/s12935-018-0590-3. eCollection 2018.
7
M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.M2 极化的肿瘤相关巨噬细胞通过 TLR4/STAT3 信号通路促进 HCC 细胞的迁移和上皮间质转化。
World J Surg Oncol. 2018 Jan 16;16(1):9. doi: 10.1186/s12957-018-1312-y.
8
Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.肿瘤相关巨噬细胞中 NOR1 蛋白的异常表达有助于 DEN 诱导的肝细胞癌的发展。
J Cell Physiol. 2018 Jun;233(6):5002-5013. doi: 10.1002/jcp.26349. Epub 2018 Jan 4.
9
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.抑制性受体LILRB1与MHC I类分子的结合可抑制巨噬细胞,是癌症免疫治疗的一个靶点。
Nat Immunol. 2018 Jan;19(1):76-84. doi: 10.1038/s41590-017-0004-z. Epub 2017 Nov 27.
10
Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.缺氧诱导因子-1α/白细胞介素-1β 信号通过巨噬细胞增强低氧炎症微环境中的肝癌上皮-间充质转化。
Hepatology. 2018 May;67(5):1872-1889. doi: 10.1002/hep.29681. Epub 2018 Mar 26.